Tuesday , October 17 2017
Home / David L. Joffe, BSPharm, CDE, FACA (page 14)

David L. Joffe, BSPharm, CDE, FACA

David L. Joffe, BSPharm, CDE, FACA
(Editor-in-Chief Diabetes In Control) A graduate of University of Kentucky College of Pharmacy, he has practiced in the Tampa Bay area since 1986, has been providing diabetes and cardiovascular care in Tampa Bay since 1995, and spent 2 years as an Eckerd Patient Care Pharmacist managing over 100 diabetes patients. Dave currently sees patients in over 30 primary care and endocrinologists offices.

September 10, 2016

dave

There have always been conversations amongst medical professionals on the best way to get patients to take the diagnosis of type 2 diabetes seriously. Most of these patients have no symptoms and find out by accident when labs are done or they go to a health fair screening. Because the ...

Read More »

September 6, 2016

dave

Many times we get rushed when working with our diabetes patients and try to squeeze in too much in a 12-minute appointment. This means either things get overlooked or our patients are confused. Based on this, it is important to take advantage of the whole patient care team, especially when ...

Read More »

Sept. 3, 2016

dave

In issue 162, published in June 2004, we had an item from the BMJ touting a polypill that could reduce heart attack and strokes in 80% of all people over 55 who had some sort of vascular problem. This pill had 6 drugs, including: a cholesterol-lowering statin; three blood-pressure medications; folic acid; ...

Read More »

August 30, 2016

dave

Three days ago I got a call from a patient who needed some insulin. The problem was, I had not seen the patient in 6 years — since I had first trained him on his insulin pump. Apparently they had gone out of town; he had prefilled cartridges with him and left them in a ...

Read More »

Aug. 27, 2016

dave

Last week in our Clinical Series we had an excerpt from International Textbook of Diabetes Mellitus, 4th Ed., looking at Beta-Cell response to nonglucose secretagogues. This text dealt with how the beta cells might be affected by more than just glucose. We are learning more about how fat. protein, and non-insulin peptides might have effects we had never ...

Read More »

August 23, 2016

dave

Last week, I had a new patient referred to me with adult onset type 1 diabetes. The patient was 63 years old and — although she had been losing weight over the past year — it was a 16 pound loss over the previous 2 weeks that got the physician concerned. An A1c test came ...

Read More »

August 20, 2016

dave

Sometimes, when we want to impress our patients with the importance of their disease, we will list all the possible effects of the disease. These include blindness, kidney failure, and amputations. But what do we tell our patients that have pre-diabetes or impaired glucose tolerance? This week, we have an ...

Read More »

August 18, 2016

dave

For years the crux of diabetes care for type 2’s has been to reduce the amount of glucose going in and the amount of glucose being absorbed. We put patients on carbohydrate-restricted diets, have them take fiber before a meal, and use medicines such as acarbose. For the most part ...

Read More »